Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Johannes Jacob Pieter Kastelein | Chief Scientific Officer | 2024-03-26 | 190,476 | $21.50 | $4.10MSell |
Johannes Jacob Pieter Kastelein | Chief Scientific Officer | 2024-03-26 | 11,197 | $22.72 | $254.40kSell |
James N. Topper | Director | 2024-03-26 | 8,429 | $21.50 | $181.22kBuy |
Louis G. Lange | Director | 2024-02-13 | 5,000 | $19.00 | $95.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James N. Topper | 16.37% | 14,610,429 | $292.94M | Insider |
Frazier Life Sciences Management LP | 13.59% | 12,131,705 | $243.24M | Institution |
Fcpm Iii Services Bv | 13.25% | 11,831,461 | $237.22M | Institution |
Nap Bv Forgrowth | 13.25% | 11,831,461 | $237.22M | Insider |
Bain Capital Life Sciences Investors LLC | 11.73% | 10,473,913 | $210.00M | Insider |
Bain Capital Life Sciences Investors LLC | 11.73% | 10,473,913 | $210.00M | Institution |
Viking Global Investors LP | 8.99% | 8,024,565 | $160.89M | Institution |
Ra Capital Management LP | 8.81% | 7,864,000 | $157.67M | Institution |
Medicxi Ventures Management Jersey Ltd | 3.21% | 2,869,565 | $57.53M | Institution |
James E. Flynn | 2.78% | 2,480,199 | $49.73M | Insider |